VIGL Insider Trading

Insider Ownership Percentage: 33.03%
Insider Buying (Last 12 Months): $15,000.00
Insider Selling (Last 12 Months): $0.00

Vigil Neuroscience Insider Trading History Chart

This chart shows the insider buying and selling history at Vigil Neuroscience by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vigil Neuroscience Share Price & Price History

Current Price: $4.22
Price Change: Price Increase of +0.23 (5.76%)
As of 07/24/2024 12:13 PM ET

This chart shows the closing price history over time for VIGL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Vigil Neuroscience Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/20/2023Ivana Magovcevic-LiebischCEOBuy4,000$3.75$15,000.00207,687View SEC Filing Icon  
11/18/2022Spyros PapapetropoulosInsiderSell300$14.00$4,200.004,000View SEC Filing Icon  
5/16/2022Clay ThorpDirectorBuy21,802$2.76$60,173.521,541,137View SEC Filing Icon  
5/5/2022Evan ThackaberrySVPBuy1,500$4.00$6,000.001,500View SEC Filing Icon  
5/3/2022Christopher VerniGeneral CounselBuy4,000$3.77$15,080.004,000View SEC Filing Icon  
5/3/2022Ivana Magovcevic-LiebischCEOBuy1,000$3.94$3,940.00203,687View SEC Filing Icon  
3/28/2022Clay ThorpDirectorBuy3,000$7.20$21,600.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Vigil Neuroscience (NASDAQ:VIGL)

83.64% of Vigil Neuroscience stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VIGL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Vigil Neuroscience Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/10/2024Vanguard Group Inc.894,473$3.05M0.0%+11.9%2.380%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio8,200$27K0.0%N/A0.023%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.64,303$0.35M0.0%-6.9%0.179%Search for SEC Filing on Google Icon
11/15/2023Laurion Capital Management LP10,839$58K0.0%-89.1%0.030%Search for SEC Filing on Google Icon
11/14/2023Deerfield Management Company L.P. Series C1,827,400$9.85M0.2%-10.9%5.093%Search for SEC Filing on Google Icon
11/14/2023PEAK6 Investments LLC23,796$0.13M0.0%+66.0%0.066%Search for SEC Filing on Google Icon
8/14/2023Deep Track Capital LP1,773,409$16.67M0.8%-12.4%4.944%Search for SEC Filing on Google Icon
8/11/2023Artal Group S.A.1,911,191$17.97M0.6%-14.8%5.328%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.7,734$73K0.0%N/A0.022%Search for SEC Filing on Google Icon
8/2/2023Bank of Montreal Can73,243$0.73M0.0%N/A0.205%Search for SEC Filing on Google Icon
5/4/2023Barclays PLC104,248$1.02M0.0%-1.6%0.292%Search for SEC Filing on Google Icon
2/14/2023683 Capital Management LLC15,092$0.19M0.0%N/A0.042%Search for SEC Filing on Google Icon
2/13/2023Artal Group S.A.2,243,352$28.04M1.6%-1.8%6.305%Search for SEC Filing on Google Icon
2/9/2023Citigroup Inc.93,927$1.17M0.0%+38.8%0.264%Search for SEC Filing on Google Icon
2/1/2023Bank of Montreal Can58,100$0.73M0.0%N/A0.163%Search for SEC Filing on Google Icon
11/15/2022BVF Inc. IL1,813,633$16.50M0.7%N/A5.097%Search for SEC Filing on Google Icon
11/15/2022Citadel Advisors LLC2,166,467$19.72M0.0%+0.1%6.089%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC28,533$0.26M0.0%N/A0.101%Search for SEC Filing on Google Icon
11/14/2022Altium Capital Management LP15,788$0.14M0.1%N/A0.056%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP130,200$0.34M0.0%N/A0.461%Search for SEC Filing on Google Icon
5/16/2022Deep Track Capital LP389,141$2.74M0.2%N/A1.377%Search for SEC Filing on Google Icon
5/12/2022Artal Group S.A.1,121,191$7.88M0.3%N/A3.966%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund8,500$60K0.0%N/A0.030%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Vigil Neuroscience logo
Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Its lead candidate is VGL101(Iluzanebart), a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also developing VG-3927, an orally-available small molecule TREM2 agonist to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations, which is being evaluated in a Phase 1 clinical trial. It has license agreement with Amgen Inc. to commercially develop, manufacture, use, distribute, and sell therapeutic products containing compounds that bind to TREM2. The company was incorporated in 2020 and is headquartered in Watertown, Massachusetts.
Read More on Vigil Neuroscience

Today's Range

Now: $4.22
Low: $4.00
High: $4.25

50 Day Range

MA: $3.88
Low: $2.51
High: $4.66

52 Week Range

Now: $4.22
Low: $2.47
High: $9.24

Volume

148,189 shs

Average Volume

296,026 shs

Market Capitalization

$158.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2

Who are the company insiders with the largest holdings of Vigil Neuroscience?

Vigil Neuroscience's top insider shareholders include:
  1. Ivana Magovcevic-Liebisch (CEO)
  2. Spyros Papapetropoulos (Insider)
Learn More about top insider investors at Vigil Neuroscience.